Topic

California

A collection of 516 issues

Krystexxa (Pegloticase) Approval with UnitedHealthcare in California: Answers to the Most Common Questions

Answer Box: Getting Krystexxa Covered by UnitedHealthcare in California UnitedHealthcare requires prior authorization for Krystexxa (pegloticase) in California with strict step therapy requiring documented failure of both allopurinol and febuxostat at maximum doses, plus G6PD testing and rheumatologist oversight. Submit PA via UnitedHealthcare provider portal with complete clinical documentation. If
5 min read

How to Get Ocrevus (Ocrelizumab) Covered by UnitedHealthcare in California: Renewal Guide, Appeal Scripts, and Timeline

Answer Box: Getting Ocrevus Covered by UnitedHealthcare in California UnitedHealthcare requires prior authorization for Ocrevus (ocrelizumab) with annual renewal documentation showing clinical response. Submit via the UHC Provider Portal with MS diagnosis confirmation, prior DMT trials, and evidence of treatment benefit (stable/improved disability scores, reduced relapses, or MRI stability)
6 min read

How to Get Vimizim (elosulfase alfa) Covered by Aetna (CVS Health) in California: Complete Prior Authorization and Appeals Guide

Getting Vimizim (elosulfase alfa) covered by Aetna (CVS Health) in California requires prior authorization with confirmed MPS IVA diagnosis, specialist prescription, and baseline functional assessments. Submit documentation via Aetna's provider portal or call 1-888-632-3862 for PA forms. If denied, file an internal appeal within 180 days, then request
5 min read